- Home
- AVB vs STE Comparison
AVB vs STE Comparison
Compare AVB & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVB
- STE
- Stock Information
- Founded
- AVB 1978
- STE 1985
- Country
- AVB United States
- STE United States
- Employees
- AVB N/A
- STE N/A
- Industry
- AVB Real Estate Investment Trusts
- STE Industrial Specialties
- Sector
- AVB Real Estate
- STE Health Care
- Exchange
- AVB Nasdaq
- STE Nasdaq
- Market Cap
- AVB 28.9B
- STE 23.9B
- IPO Year
- AVB 1994
- STE 1992
- Fundamental
- Price
- AVB $206.99
- STE $235.63
- Analyst Decision
- AVB Buy
- STE Buy
- Analyst Count
- AVB 14
- STE 9
- Target Price
- AVB $235.36
- STE $261.00
- AVG Volume (30 Days)
- AVB 867.7K
- STE 539.4K
- Earning Date
- AVB 07-30-2025
- STE 08-05-2025
- Dividend Yield
- AVB 3.38%
- STE 0.97%
- EPS Growth
- AVB 19.58
- STE 63.01
- EPS
- AVB 8.03
- STE 6.21
- Revenue
- AVB $2,988,732,000.00
- STE $5,459,515,000.00
- Revenue This Year
- AVB $3.63
- STE $7.59
- Revenue Next Year
- AVB $5.21
- STE $6.04
- P/E Ratio
- AVB $25.76
- STE $37.87
- Revenue Growth
- AVB 5.89
- STE 6.24
- 52 Week Low
- AVB $180.40
- STE $200.98
- 52 Week High
- AVB $239.29
- STE $252.79
- Technical
- Relative Strength Index (RSI)
- AVB 52.50
- STE 42.54
- Support Level
- AVB $205.03
- STE $239.74
- Resistance Level
- AVB $209.39
- STE $244.26
- Average True Range (ATR)
- AVB 3.61
- STE 3.15
- MACD
- AVB 0.23
- STE -1.56
- Stochastic Oscillator
- AVB 69.78
- STE 10.51
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 289 apartment communities with over 87,000 units and is developing 17 additional properties with over 6,000 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.